Flamingo Takes Flight: Soaring High with Advanced Pharma Mfg in Maharashtra

Flamingo Pharma is gearing up for a significant venture with its Active Pharmaceuticals Intermediates (API) Manufacturing Unit project in Pimpalgaon - Pandhari, Aurangabad, Maharashtra. With a project cost of Rs. 14.8 Crores, the facility aims to contribute substantially to the pharmaceutical industry's production capabilities.

The API manufacturing unit boasts a robust production capacity of 41 MT/Month, encompassing eight different products. The project is characterized by a comprehensive environmental management plan, with an allocated cost of Rs. 1.80 Crore, demonstrating Flamingo Pharma's commitment to responsible and sustainable operations.

Noteworthy details include the water requirement of 48 CMD, sourced partially from recycling (28.5 CMD) and fresh well water from a nearby location. Power needs, totaling 250 KVA, will be fulfilled through the Maharashtra State Electricity Distribution Company (MSEDCL). To facilitate operations, the project anticipates employing 24 skilled and unskilled personnel.

Flamingo Pharma also emphasizes Corporate Environmental Responsibility (CER) by allocating Rs. 0.296 Crore (2% of the total cost) towards environmental initiatives. While the information provided offers a glimpse into the project's scope, it is advisable to consult official documents, such as the Environmental Impact Assessment (EIA) report, for a more comprehensive understanding.

As the project is in the early stages, specific details about the API and intermediates, construction timelines, and environmental impacts may not be readily available. Further research into areas such as wastewater treatment, air emissions, waste management, social impact, and regulatory approvals will provide a more complete and informed perspective on Flamingo Pharma's ambitious endeavor.

News by Rahul Yelligetti